Target
Histone-lysine N-methyltransferase SMYD3
Ligand
BDBM377876
Substrate
n/a
Meas. Tech.
SMYD3 Biochemical Assay
IC50
>100000±n/a nM
Citation
 Foley, MAKuntz, KWMills, JEMitchell, LHMunchhof, MJHarvey, DM Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer US Patent  US10266526 Publication Date 4/23/2019 
Target
Name:
Histone-lysine N-methyltransferase SMYD3
Synonyms:
SET and MYND domain-containing protein 3 | SMYD3 | SMYD3_HUMAN | ZMYND1 | ZNFN3A1 | Zinc finger MYND domain-containing protein 1
Type:
Enzyme
Mol. Mass.:
49101.22
Organism:
Homo sapiens (Human)
Description:
Q9H7B4-2
Residue:
428
Sequence:
MEPLKVEKFATAKRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS
  
Inhibitor
Name:
BDBM377876
Synonyms:
N-(1-((4-acetamidophenyl)sulfonyl)piperidin-4-yl)-1-methyl-1H-pyrazole-5-carboxamide | US10266526, Compound 7
Type:
Small organic molecule
Emp. Form.:
C18H23N5O4S
Mol. Mass.:
405.471
SMILES:
CC(=O)Nc1ccc(cc1)S(=O)(=O)N1CCC(CC1)NC(=O)c1ccnn1C
Structure:
Search PDB for entries with ligand similarity: